- What is SBI JI Innovation's primary investment focus?
- SBI JI Innovation is a biopharma and high-tech focused venture capital firm. It actively invests in Israeli or Israel-related venture-backed companies across various developmental stages.
- When was SBI JI Innovation formed and what is its origin?
- SBI JI Innovation was formed in early 2017 as a partnership between SBI Holdings of Japan and Vertex Israel.
- What is SBI JI Innovation's geographic investment preference?
- SBI JI Innovation prefers to invest in companies in Israel and Asia, aiming to bridge investment opportunities and technological advancements between the two regions.
- What investment stages does SBI JI Innovation cover?
- SBI JI Innovation invests across a broad range of stages, including Pre-Seed, Seed, Series A, Series B, Series C, and Mature companies.
- What are the preferred sectors for SBI JI Innovation's investments?
- SBI JI Innovation's preferred sectors include biopharma, healthcare, immunology, immunotherapy, Alzheimer's, high-tech, and fintech.
- Who are the General Partners at SBI JI Innovation?
- The General Partners at SBI JI Innovation include David Heller and Ran Gartenberg, who also serves as CFO.
- Does SBI JI Innovation have a specific fund mentioned?
- Yes, SBI JI Innovation launched the SBI JI Innovation Fund in 2017.
- What is SBI JI Innovation's thesis regarding its investments?
- SBI JI Innovation invests in exceptional VC-backed life science and high-tech companies with cutting-edge technology, strong management, and scalable roadmaps. The firm is committed to Israel and strives to create an ecosystem that serves as a bridge between Israel and Asia.